1. Home
  2. NTHI vs GPMT Comparison

NTHI vs GPMT Comparison

Compare NTHI & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • GPMT
  • Stock Information
  • Founded
  • NTHI 2008
  • GPMT 2015
  • Country
  • NTHI United States
  • GPMT United States
  • Employees
  • NTHI N/A
  • GPMT N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • GPMT Real Estate Investment Trusts
  • Sector
  • NTHI Health Care
  • GPMT Real Estate
  • Exchange
  • NTHI Nasdaq
  • GPMT Nasdaq
  • Market Cap
  • NTHI 142.5M
  • GPMT 122.5M
  • IPO Year
  • NTHI N/A
  • GPMT 2017
  • Fundamental
  • Price
  • NTHI $4.26
  • GPMT $2.39
  • Analyst Decision
  • NTHI
  • GPMT Buy
  • Analyst Count
  • NTHI 0
  • GPMT 3
  • Target Price
  • NTHI N/A
  • GPMT $2.75
  • AVG Volume (30 Days)
  • NTHI 23.3K
  • GPMT 542.7K
  • Earning Date
  • NTHI 01-01-0001
  • GPMT 08-04-2025
  • Dividend Yield
  • NTHI N/A
  • GPMT 8.77%
  • EPS Growth
  • NTHI N/A
  • GPMT N/A
  • EPS
  • NTHI N/A
  • GPMT N/A
  • Revenue
  • NTHI $79,990.00
  • GPMT N/A
  • Revenue This Year
  • NTHI N/A
  • GPMT N/A
  • Revenue Next Year
  • NTHI N/A
  • GPMT $31.11
  • P/E Ratio
  • NTHI N/A
  • GPMT N/A
  • Revenue Growth
  • NTHI 13.52
  • GPMT N/A
  • 52 Week Low
  • NTHI $4.11
  • GPMT $1.61
  • 52 Week High
  • NTHI $25.00
  • GPMT $3.66
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • GPMT 48.51
  • Support Level
  • NTHI N/A
  • GPMT $2.26
  • Resistance Level
  • NTHI N/A
  • GPMT $2.62
  • Average True Range (ATR)
  • NTHI 0.00
  • GPMT 0.13
  • MACD
  • NTHI 0.00
  • GPMT -0.04
  • Stochastic Oscillator
  • NTHI 0.00
  • GPMT 31.82

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

Share on Social Networks: